There is 1 paper on NADC3 in aging research: none in people yet, 1 in cells.
At a glance
The findings reach cells, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funders: National Key Research and Development Program of China and 1 more
- Cells1
Effects
3NAD/NADH ratio
downin human cells1
1 study
NAD/NADH ratio
downin human cells1
NADC3 decreases NAD/NADH ratio in human cells (NaDC3 overexpression in WI38 cells).
“The NAD(+)/NADH ratio in WI38/hNaDC3 cells was also decreased.”
CellsNaDC3 overexpression in WI38 cells
Mechanisms of ageing and development
SIRT1
downin human cells1
1 study
SIRT1
downin human cells1
NADC3 decreases SIRT1 in human cells (NaDC3 overexpression in WI38 and MRC-5 cells).
“Meanwhile, the level of SIRT1 activity was down-regulated.”
CellsNaDC3 overexpression in WI38 and MRC-5 cells
Mechanisms of ageing and development
Aging-related phenotypes
upin human cells1
1 study
Aging-related phenotypes
upin human cells1
NADC3 increases aging-related phenotypes in human cells (overexpression in WI38 and MRC-5 cells).
“After NaDC3 was overexpressed in two human embryo lung fibroblastic cell lines, WI38 and MRC-5, we found that the cells displayed aging-related phenotypes in advance.”
Cellsoverexpression in WI38 and MRC-5 cells
Mechanisms of ageing and development